Skip to content

Construction of specialized disease database of ANCA related vasculitis in children

Construction of specialized disease database of ANCA related vasculitis in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063743
Enrollment
Unknown
Registered
2022-09-15
Start date
2022-09-15
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ANCA associated vasculitis

Interventions

None listed

Sponsors

Children's Hospital Affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Disease name: (1) ICD-10 code range (first diagnosis code of discharge diagnosis, other diagnosis codes of discharge diagnosis, outpatient diagnosis code): Vasculitis (M30-M31, D69.0): Takayasu arteritis, polyarteritis nodosa , Kawasaki disease, ANCA-associated vasculitis, allergic purpura, Behcet's disease, other vasculitis; (2) Diagnosis names include (discharge diagnosis, outpatient diagnosis before standardization): connective tissue disease; autoimmunity; autoinflammation; periodic fever; lupus; SLE; dermatomyositis; JDM; anti-Jo; anti-J0; anti-synthetase Antibodies; polymyositis; IgG4; Sjogren's syndrome; SS; antiphospholipid antibodies; APS; systemic sclerosis; SSc; scleroderma; overlap syndrome; MCTD; Kimura disease; Kimura; juvenile arthritis; JIA; juvenile arthritis Oncogenic arthritis; Still; Still; Juvenile polyarthritis; Vasculitis; Arteritis; Kawasaki disease; ANCA; Purpuric vasculitis; allergic purpura; arthritic purpura; purpura nephritis; Behcet; Behcet; Behcet; Behet; (immunodeficiency disease NOT AIDS); IgA deficiency; common variable immunodeficiency disease; hyper-IgM syndrome; SCID; adenosine deaminase deficiency; hyperimmunoglobulin E; hyper-IgE; PI3K; APDS; Wiskort; Chronic granulomatous disease; CGD; autoimmune lymphoproliferative syndrome; XLP; X-linked lymphoproliferative syndrome; ataxia telangiectasia; reactive arthritis; Reiter syndrome; Reiter; autoinflammation ;Periodic fever; PFAPA; Cold inflammatory factor-associated periodic syndrome; Type I interferon disease; AGS; Aicardi;; STING-associated infantile-onset vascular disease; SAVI; rheumatic fever; macrophage activation; hemophagocytosis; rheumatic immunity; 2. Age range: <= 18 years old; 3. Time range: unlimited; 4. Patient range: inpatients, outpatients; 5. Department scope: no limit.

Exclusion criteria

Exclusion criteria: Children who do not meet the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Biochemical indexes of blood immunity;Proteinuria index;

Countries

China

Contacts

Public ContactMo Wang

Children's Hospital Affiliated to Chongqing Medical University

wangmo_cqmu@163.com+86 13983649255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026